Site içinde arama yapın

bir ses eklendi Health

2026-01-21 10:19:06 -

Transarterial Chemoembolization Market: Is 2026 the Year "Drug-Eluting Beads" Become the Global Standard?

As of January 21, 2026, the global transarterial chemoembolization (TACE) market is identifying as a high-growth pillar of interventional oncology, with its 2026 valuation reaching approximately $11.24 billion. The 2026 landscape is defined by a steady 4.5% to 5.4% CAGR and a significant pivot toward DEB-TACE (Drug-Eluting Bead TACE), which offers a more controlled release of chemotherapy...

0 Yorumlar 0 hisse senetleri 634 Views 0 önizleme